Crispr Therapeutics shares owned by Advisor Group Holdings
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Advisor Group Holdings
from 13F filings
Historical chart of Advisor Group Holdings investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Advisor Group Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.6M | 56k | 64.82 |
| 2025-06-30 | $1.9M | 49k | 39.32 |
| 2025-03-31 | $1.5M | 44k | 34.03 |
| 2024-12-31 | $2.1M | 46k | 46.96 |
| 2024-09-30 | $4.0M | 85k | 46.98 |
| 2024-03-31 | $6.2M | 91k | 68.16 |
| 2023-12-31 | $5.7M | 91k | 62.60 |
| 2023-09-30 | $4.7M | 104k | 45.39 |
| 2023-06-30 | $5.4M | 96k | 56.14 |
| 2023-03-31 | $3.8M | 85k | 45.23 |
| 2022-12-31 | $2.8M | 69k | 40.52 |
| 2022-09-30 | $3.3M | 51k | 65.37 |
| 2022-06-30 | $3.1M | 51k | 60.83 |
| 2022-03-31 | $3.2M | 52k | 62.82 |
| 2021-12-31 | $3.6M | 48k | 75.79 |
| 2021-09-30 | $4.7M | 42k | 111.94 |
| 2021-06-30 | $5.7M | 35k | 162.09 |
| 2021-03-31 | $3.7M | 30k | 121.91 |
| 2020-12-31 | $2.7M | 18k | 153.24 |
| 2020-09-30 | $1.8M | 22k | 83.93 |
| 2020-06-30 | $1.4M | 19k | 73.21 |
| 2020-03-31 | $811k | 19k | 42.26 |